Abstract
The extracolonic tumor spectrum of hereditary nonpolyposis colorectal cancer (HNPCC) includes cancer of the endometrium, ovaries, stomach, biliary tract, and urinary tract. This study was designed to determine the penetrance of colorectal and extracolonic tumors in HNPCC mutation carriers. Forty-nine patients (22 females and 27 males) were identified with an MSH2 germline mutation, and 56 patients (28 females and 28 males) were identified with an MLH1 mutation. Cumulative incidence by age 60 (lifetime risk) and mean age of cancer diagnosis were compared. The lifetime risk of extracolonic cancers in MSH2 and MLH1 carriers was 48% and 11% respectively (P = 0.016). Extracolonic cancer risk in MSH2 females and males was 69% and 34%, respectively (P = 0.042). Mean age of extracolonic cancer diagnosis was significantly older for MSH2 males than females (55.4 vs. 39.0, P = 0.013). No difference was observed in colorectal cancer risk between MLH1 and MSH2 carriers (84% vs. 71%). Colorectal cancer risk was 96% in MSH2 males compared to 39% in MSH2 females (P = 0.034). No differences in colorectal and extracolonic cancer risks between MLH1 females and males were identified. The risk of extracolonic cancer by age 60 was greater in MSH2 mutation carriers than in MLH1 carriers. Gender differences in colorectal and extracolonic cancer risk were observed for MSH2 carriers only. These phenotypic features of HNPCC genotypes may have clinical significance in the design of genotype-specific screening, surveillance, and follow-up for affected individuals.
Similar content being viewed by others
References
Winawer SJ, Fletcher RH, Miller R, et al. Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology 1997; 112:594–642.
Bellacosa A, Genuardi M, Anti M, Viel A, Ponz de Leon M. Hereditary nonpolyposis colorectal cancer: Review of clinical, molecular genetics, and counseling aspects. Am J Med Genet 1996;62:353–364.
Marra G, Boland CR. Hereditary nonpolyposis colorectal cancer: The syndrome, the genes, and historical perspectives. J Natl Cancer Inst 1995;87:1114–1125.
Mecklin JP, Jarvinen HJ, Hakkiluoto A, et al. Frequency of hereditary nonpolyposis colorectal cancer. A prospective multicenter study in Finland. Dis Colon Rectum 1995;38:588–593.
Lynch HT, Smyrk T. Hereditary nonpolyposis colorectal can- cer (Lynch syndrome). An updated review. Cancer 1996;78:1149–1167.
Tomoda H, Baba H, Oshiro T. Clinical manifestations in patients with hereditary nonpolyposis colorectal cancer. J Surg Oncol 1996;61:262–266.
D’Emilia JC, Rodriguez-Bigas MA, Petrelli N-J. The clinical and genetic manifestations of hereditary nonpolyposis colorectal carcinoma. AmJ Surg 1995;169:368–372.
Percesepe A, Anti M, Marra G, et al. Role of clinical criteria in the diagnosis of hereditary non-polyposis colorectal cancer (HNPCC): Results of a multivariate analysis. Int J Cancer 1994;58:799–802.
Lynch HT, Smyrk TC, Cavalieri J, Lynch JE. Identification of an I-INPCC family. AmJ Gastroenterol 1994;89:605–609.
Whitehouse A, Taylor GR, Deeble J, et al. A carboxy terminal domain of the hMSH-2 gene product is sufficient for binding specific mismatched oligonucleotides. Biochem Biophys Res Commun 1996;225:289–295.
Mellon I, Rajpal DK, Koi M, Boland CR, Champe GN. Transcription-coupled repair deficiency and mutations in human mismatch repair genes. Science 1996;272:557–560.
Brown ML, Kessler LG. Use of gene tests to detect hereditary predisposition to cancer: What do we know about cost effectiveness? IntJ Cancer 1996;69:55–57.
Papadopoulos N, Leach FS, Kinzler KW, Vogelstein B. Monoallelic mutation analysis (MAMA) for identifying germline mutations. Nat Genet 1995;11:99–102.
Wijnen J, Vasen H, Khan PM, et al. Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradientgel electrophoresis. AmJ Hum Genet 1995;56:1060–1066.
Kolodner RD, Hall NR, Lipford J, et al. Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations. Genomics 1994;24:516–526.
Horii A, Han HJ, Sasaki S, Shimada M, Nakamura Y. Cloning, characterization and chromosomal assignment of the human genes homologous to yeast PMS 1, a member of mismatch repair genes. Bioehem Biophys Res Commun 1994; 204:1257–1264.
Nystrom-Lahti M, Parsons R, Sistonen P, et al. Mismatch repair genes on chromosomes 2p and 3p account for a major share of hereditary nonpolyposis colorectal cancer families evaluable by linkage. AmJ Hum Genet 1994;55:659–665.
Liu B, Parsons RE, Hamilton SR, et al. hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res 1994;54:4590–4459.
Papadopoulos N, Nicolaides NC, Wei Y-F, et al. Mutation of a mutL homolog in hereditary colon cancer [see comments]. Science 1994;263:1625–1629.
Rhyu M. Molecular mechanisms underlying hereditary nonpolyposis colorectal carcinoma. J Nat Cancer Inst 1996; 88:240–251.
Kohonen-Corish M, Ross VL, Doe WF, et al. RNA-based mutation screening in hereditary nonpolyposis colorectal cancer. AmJ Hum Genet 1996;59:818–824.
Luce MC, Binnie CG, Cayouette MC, Kam-Morgan LN. Identification of DNA mismatch repair gene mutations in hereditary nonpolyposis colon cancer. Int J Cancer 1996; 69:50–52.
Wijnen J, Khan PM, Vasen H, et al. Majority ofhMLH1 mutations responsible for hereditary nonpolyposis colorectal cancer cluster at the exonic region 15–16. Am J Hum Genet 1996;58:300–307.
Piepoli A, Santoro R, Cristofaro G, et al. Linkage analysis identifies gene carriers among members of families with hereditary nonpolyposis colorectal cancer. Gastroenterology 1996;110:1404–1409.
Aarnio M, Mecklin JP, Aaltonen LA, et al. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. IntJ Cancer 1995;64:430–433.
Benatti P, Sassatelli R, Roncucci L, et al. Tumor spectrum in hereditary non-polyposis colorectal cancer (HNPCC) and in families with "suspected HNPCC." A population-based study in northern Italy. IntJ Cancer 1993;54:371–377.
Mecklin JP, Jarvinen HJ. Tumor spectrum in cancer family syndrome (hereditary nonpolyposis colorectal cancer). Cancer 1991;68:1109–1112.
Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993;71:677–685.
Vasen HF, Offerhaus GJ, Jager FC, et al. The tumor spectrum in hereditary nonpolyposis colorectal cancer: A study of 24 kindreds in The Netherlands. IntJ Cancer 1990;46:31–34.
Vasen HF, Wijnen JT, Menko FH, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996;110:1020–1027.
Dunlop MG, Farrington SM, Carothers AD, et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 1997;6:105–110.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lin, K.M., Shashidharan, M., Thorson, A.G. et al. Cumulative incidence of colorectal and extracolonic cancers in mlh1 and msh2 mutation carriers of hereditary nonpolyposis colorectal cancer. J Gastrointest Surg 2, 67–71 (1998). https://doi.org/10.1016/S1091-255X(98)80105-4
Issue Date:
DOI: https://doi.org/10.1016/S1091-255X(98)80105-4